Record Information |
---|
Version | 2.0 |
---|
Created at | 2022-05-11 16:55:02 UTC |
---|
Updated at | 2022-05-11 16:55:02 UTC |
---|
NP-MRD ID | NP0087621 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | 17alpha,21-Dihydroxy-5beta-pregnane-3,11,20-trione |
---|
Description | 17A,21-Dihydroxy-5b-pregnane-3,11,20-trione, also known as 4,5beta-dihydrocortisone or 5beta-pregnane-17alpha,21-diol-3,11,20-trione, belongs to the class of organic compounds known as 21-hydroxysteroids. These are steroids carrying a hydroxyl group at the 21-position of the steroid backbone. Thus, 17a,21-dihydroxy-5b-pregnane-3,11,20-trione is considered to be a steroid lipid molecule. 17A,21-Dihydroxy-5b-pregnane-3,11,20-trione is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. Within humans, 17a,21-dihydroxy-5b-pregnane-3,11,20-trione participates in a number of enzymatic reactions. In particular, 17a,21-dihydroxy-5b-pregnane-3,11,20-trione can be converted into cortisone through its interaction with the enzyme 3-oxo-5-beta-steroid 4-dehydrogenase. In addition, 17a,21-dihydroxy-5b-pregnane-3,11,20-trione can be biosynthesized from tetrahydrocortisone through its interaction with the enzyme aldo-keto reductase family 1 member C4. A 4,17a,21-Dihydroxy-5b-pregnane-3,11,20-trione that has beta- configuration at position 5. In humans, 17a,21-dihydroxy-5b-pregnane-3,11,20-trione is involved in the metabolic disorder called the 21-hydroxylase deficiency (cyp21) pathway. |
---|
Structure | [H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CC[C@]2([H])CC(=O)CC[C@]12C InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h12,14-15,18,22,26H,3-11H2,1-2H3/t12-,14+,15+,18-,19+,20+,21+/m1/s1 |
---|
Synonyms | Value | Source |
---|
17alpha,21-Dihydroxy-5beta-pregnane-3,11,20-trione | ChEBI | 4,5beta-Dihydrocortisone | ChEBI | 5-Dihydrocortisone | ChEBI | 5beta-Pregnane-17alpha,21-diol-3,11,20-trione | ChEBI | 17Α,21-dihydroxy-5β-pregnane-3,11,20-trione | Generator | 4,5b-Dihydrocortisone | Generator | 4,5Β-dihydrocortisone | Generator | 5b-Pregnane-17a,21-diol-3,11,20-trione | Generator | 5Β-pregnane-17α,21-diol-3,11,20-trione | Generator | 17,21-Dihydroxy-5-beta-pregnane-3,11,20-trione | HMDB | 17,21-Dihydroxy-5b-pregnane-3,11,20-trione | HMDB | 4,5-b-Dihydrocortisone | HMDB | 4,5-beta-Dihydrocortisone | HMDB | 5 beta-Pregnan-17 alpha,21-dihydroxy-3,11,20-trione | HMDB | 5 beta-Dihydrocortisone | HMDB |
|
---|
Chemical Formula | C21H30O5 |
---|
Average Mass | 362.4599 Da |
---|
Monoisotopic Mass | 362.20932 Da |
---|
IUPAC Name | (1S,2S,7R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecane-5,17-dione |
---|
Traditional Name | dihydrocortisone |
---|
CAS Registry Number | Not Available |
---|
SMILES | [H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CC[C@]2([H])CC(=O)CC[C@]12C |
---|
InChI Identifier | InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h12,14-15,18,22,26H,3-11H2,1-2H3/t12-,14+,15+,18-,19+,20+,21+/m1/s1 |
---|
InChI Key | YCLWEYIBFOLMEM-FNLRALKVSA-N |
---|
Experimental Spectra |
---|
|
| Not Available | Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 21-hydroxysteroids. These are steroids carrying a hydroxyl group at the 21-position of the steroid backbone. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Hydroxysteroids |
---|
Direct Parent | 21-hydroxysteroids |
---|
Alternative Parents | |
---|
Substituents | - Progestogin-skeleton
- 21-hydroxysteroid
- 20-oxosteroid
- Pregnane-skeleton
- 3-oxosteroid
- 11-oxosteroid
- Oxosteroid
- 17-hydroxysteroid
- 3-oxo-5-beta-steroid
- Cyclic alcohol
- Tertiary alcohol
- Alpha-hydroxy ketone
- Ketone
- Cyclic ketone
- Alcohol
- Hydrocarbon derivative
- Organooxygen compound
- Organic oxide
- Organic oxygen compound
- Primary alcohol
- Carbonyl group
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | - 4,5-dihydrocortisone (CHEBI:18093 )
- C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives (C05469 )
- C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives (LMST02030095 )
|
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|